Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 100651-100700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04562558
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
NA
Active, not recruiting
228 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2025
7 conditions
1 sponsor
1 location
NCT04378400
An Institutional Audit of the Short Term Complications and Long Term Outcomes of Patients Undergoing Laparoscopic Sacrocolpopexy for Vault/cervical Prolapse.
N/A
Enrolling by invitation
250 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04174703
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
NA
Enrolling by invitation
160 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2026
5 conditions
2 sponsors
1 location
NCT04400695
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
PHASE3
Recruiting
366 participants
Started: Sep 29, 2020 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT04210505
Nasal Decolonization of Dialysis Patients Noses
PHASE4
Active, not recruiting
302 participants
Started: Sep 29, 2020 · Completed: Jan 31, 2024
1 condition
7 sponsors
5 locations
NCT04405700
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
N/A
Recruiting
2,800 participants
Started: Sep 29, 2020 · Completed: May 31, 2026
4 conditions
1 sponsor
1 location
NCT04666727
Role of Diet on the Microbiome of the Digestive System
N/A
Recruiting
30 participants
Started: Sep 29, 2020 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT04317664
Intervention to Improve Driving Practices Among High-Risk Teen Drivers
PHASE3
Recruiting
480 participants
Started: Sep 28, 2020 · Completed: Dec 15, 2025
4 conditions
4 sponsors
1 location
NCT04422236
A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Surgery
N/A
Active, not recruiting
200 participants
Started: Sep 28, 2020 · Completed: May 31, 2025
4 conditions
1 sponsor
1 location
NCT04533958
Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy
NA
Recruiting
60 participants
Started: Sep 28, 2020 · Completed: Feb 28, 2027
1 condition
1 sponsor
6 locations
NCT07104513
Efficacy and Influencing Factors of Repeated Low-level Red-light in Myopia
N/A
Active, not recruiting
3,000 participants
Started: Sep 28, 2020 · Completed: Jul 28, 2030
1 condition
1 sponsor
2 locations
NCT07186010
Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy
N/A
Recruiting
50 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT04579835
Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)
N/A
Recruiting
45 participants
Started: Sep 28, 2020 · Completed: Sep 28, 2026
2 conditions
1 sponsor
1 location
NCT06387498
Testicular Tissue Cryopreservation (TTC)
NA
Recruiting
60 participants
Started: Sep 28, 2020 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT04360265
Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA
PHASE3
Enrolling by invitation
41 participants
Started: Sep 28, 2020 · Completed: Aug 31, 2027
4 conditions
1 sponsor
4 locations
NCT04214834
Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
PHASE3
Active, not recruiting
189 participants
Started: Sep 28, 2020 · Completed: Jun 30, 2026
1 condition
2 sponsors
24 locations
NCT04285112
SPRINT: Signature for Pain Recovery IN Teens
N/A
Active, not recruiting
275 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2025
4 conditions
5 sponsors
4 locations
NCT04186832
Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy
NA
Active, not recruiting
50 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT04444869
Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
PHASE2
Recruiting
28 participants
Started: Sep 28, 2020 · Completed: Jun 30, 2026
4 conditions
1 sponsor
1 location
NCT04450628
Esophagogastric Junction Distensibility During Hiatal Hernia Repair
NA
Recruiting
50 participants
Started: Sep 28, 2020 · Completed: Aug 31, 2026
2 conditions
2 sponsors
1 location
NCT04618653
Comprehensive Process Model of AA-related Behavior Change
N/A
Active, not recruiting
192 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04606771
A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC
PHASE2
Active, not recruiting
30 participants
Started: Sep 28, 2020 · Completed: Mar 30, 2026
1 condition
1 sponsor
21 locations
NCT04156061
Effect of the SCOT-HEART 2 Trial on Lifestyle.
NA
Recruiting
400 participants
Started: Sep 28, 2020 · Completed: Jul 7, 2027
2 conditions
3 sponsors
1 location
NCT04494672
A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System
NA
Recruiting
96 participants
Started: Sep 28, 2020 · Completed: Aug 1, 2025
1 condition
1 sponsor
1 location
NCT04564521
Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.
NA
Recruiting
36 participants
Started: Sep 28, 2020 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT04543617
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
PHASE3
Active, not recruiting
760 participants
Started: Sep 28, 2020 · Completed: Mar 31, 2027
1 condition
1 sponsor
165 locations
NCT04501120
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
PHASE1/PHASE2
Recruiting
458 participants
Started: Sep 28, 2020 · Completed: Sep 30, 2029
2 conditions
2 sponsors
12 locations
NCT04639297
NeuroVision vs Standard Neuromonitoring
NA
Recruiting
148 participants
Started: Sep 28, 2020 · Completed: Jun 20, 2027
1 condition
1 sponsor
1 location
NCT04688411
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
NA
Recruiting
40 participants
Started: Sep 28, 2020 · Completed: Feb 1, 2025
4 conditions
2 sponsors
1 location
NCT04420754
Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer
PHASE1
Active, not recruiting
70 participants
Started: Sep 28, 2020 · Completed: Aug 4, 2030
2 conditions
1 sponsor
4 locations
NCT04685226
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
310 participants
Started: Sep 27, 2020 · Completed: Feb 25, 2028
1 condition
1 sponsor
24 locations
NCT04333706
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
PHASE1/PHASE2
Recruiting
65 participants
Started: Sep 26, 2020 · Completed: Sep 1, 2027
5 conditions
2 sponsors
3 locations
NCT04528004
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
EARLY_PHASE1
Active, not recruiting
32 participants
Started: Sep 26, 2020 · Completed: Jul 31, 2025
3 conditions
2 sponsors
1 location
NCT04213014
Guys/Girls Opt for Activities for Life Trial (GOAL) to Increase Young Adolescents' Physical Activity and Healthy Eating
NA
Active, not recruiting
935 participants
Started: Sep 26, 2020 · Completed: Aug 31, 2026
1 condition
3 sponsors
2 locations
NCT04738162
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
PHASE2
Recruiting
80 participants
Started: Sep 25, 2020 · Completed: Jun 30, 2025
1 condition
3 sponsors
7 locations
NCT04375228
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
PHASE2
Active, not recruiting
8 participants
Started: Sep 25, 2020 · Completed: Feb 28, 2026
2 conditions
2 sponsors
3 locations
NCT04488822
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
PHASE3
Active, not recruiting
40 participants
Started: Sep 25, 2020 · Completed: Feb 28, 2026
1 condition
1 sponsor
9 locations
NCT04555174
BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry
N/A
Active, not recruiting
872 participants
Started: Sep 25, 2020 · Completed: Feb 19, 2027
2 conditions
2 sponsors
41 locations
NCT03682081
Interventions for Patients With Alzheimer's Disease and Dysphagia
NA
Active, not recruiting
76 participants
Started: Sep 25, 2020 · Completed: Nov 30, 2025
3 conditions
2 sponsors
1 location
NCT04489173
TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer
PHASE2
Active, not recruiting
52 participants
Started: Sep 25, 2020 · Completed: Nov 30, 2025
2 conditions
5 sponsors
10 locations
NCT04288427
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
NA
Recruiting
120 participants
Started: Sep 25, 2020 · Completed: Nov 30, 2025
8 conditions
2 sponsors
1 location
NCT04483739
Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
PHASE3
Active, not recruiting
302 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2032
1 condition
4 sponsors
41 locations
NCT04882904
Continuous Measurement of Activity in Patients with Muscle Pathology and in Control Subjects. ActiSLA Part.
NA
Recruiting
45 participants
Started: Sep 25, 2020 · Completed: May 31, 2025
1 condition
3 sponsors
1 location
NCT04676204
Relationship Between Oral DMT Burden and Adherence in MS
N/A
Enrolling by invitation
323 participants
Started: Sep 25, 2020 · Completed: Jul 11, 2026
2 conditions
1 sponsor
1 location
NCT04571138
A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
PHASE1/PHASE2
Recruiting
42 participants
Started: Sep 25, 2020 · Completed: Feb 29, 2040
2 conditions
1 sponsor
5 locations
NCT04739826
Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
N/A
Recruiting
491 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04020809
Neoadjuvant Atezolizumab in Cutaneous Melanoma
PHASE1
Active, not recruiting
20 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04522700
Reconstruction of Maxillary and Midfacial Defects Using Latissimus Dorsi Scapular Free Flaps
NA
Not yet recruiting
30 participants
Started: Sep 25, 2020 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT03641456
VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma
PHASE2
Recruiting
50 participants
Started: Sep 25, 2020 · Completed: Dec 30, 2025
3 conditions
1 sponsor
1 location
NCT04228367
JuggerStitch Post Market Clinical Follow-up Study
NA
Recruiting
104 participants
Started: Sep 25, 2020 · Completed: Apr 30, 2026
2 conditions
1 sponsor
6 locations
Previous
1
More pages
2011
2012
2013
2014
2015
2016
2017
More pages
2369
Next